Rx (Prescription Medicine)
USD $ 30.00
Revolade 25mg Tablet 是一种用于治疗特定类型贫血的药物，特别是慢性免疫性血小板减少症（ITP）和严重骨髓抑制性贫血（SAA）。其活性成分Eltrombopag通过刺激骨髓生成更多血小板发挥作用。血小板对血液凝固和防止过度出血至关重要。当其他疗法无效时，医生通常会开具Revolade。
对于慢性免疫性血小板减少症（ITP），Revolade 用于尚未对糖皮质激素、免疫球蛋白或脾切除术作出反应的成人患者。对于严重骨髓抑制性贫血（SAA），它与免疫抑制治疗联合使用，适用于对既往免疫抑制治疗不 responsive 的成人患者。
Revolade 25mg Tablet 的剂量由医生根据您的具体病情和治疗反应确定。通常每日一次，可与食物同服或空腹服用。请勿压碎或咀嚼，整片吞服。常见不良反应可能包括恶心、腹泻、头痛和肌肉疼痛。更严重的不良反应可能发生，因此如有任何疑虑，请与您的医疗提供者讨论。Revolade 应储存在室温下，远离潮湿和热源。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Pack Quantity | |
| Strength |
其他品牌的 Eltrombopag 25 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
